NEWS RSS Streams

Community Rock Band plays second annual show at Downtown Plaza  SooToday.com

Fighting in Yemen displaces more civilians, as Trump says a decision on Iran is coming.

1. Odelein dies at 58, was first Blue Jackets captain  NHL.com
2. Former Penguins defenseman Lyle Odelein dies at 58  Pittsburgh Post-Gazette
3. Blue Jackets honor Odelein with pregame ceremony  NHL.com
4. Montreal Canadiens defenceman Lyle Odelein, who won a Stanley Cup in 1993, dead at 58  CBC
5. First Captain Of The Columbus Blue Jackets Passes Away At 58  Yahoo

1. Argonauts can't get in from goal line in final minute, lose to Lions  Sportsnet.ca
2. Argonauts comes up short on final drive and fall to Lions  Toronto Star
3. Whyte boots club-record eight field goals to earn Lions 24-17 win over Argonauts  CTV News
4. Must See: Lions' defence stands tall to deny the Argos a late score  TSN
5. B.C. Lions' offence leaves meat on the bone, defence cleans up their leftovers in victory over Argos (& 10 other thoughts)  3DownNation

1. Argonauts can't get in from goal line in final minute, lose to Lions  Sportsnet.ca
2. Argonauts comes up short on final drive and fall to Lions  Toronto Star
3. Whyte boots club-record eight field goals to earn Lions 24-17 win over Argonauts  CTV News
4. Must See: Lions' defence stands tall to deny the Argos a late score  TSN
5. B.C. Lions' offence leaves meat on the bone, defence cleans up their leftovers in victory over Argos (& 10 other thoughts)  3DownNation

1. Odelein dies at 58, was first Blue Jackets captain  NHL.com
2. Lyle Odelein passes away at age 58 | Montréal Canadiens  NHL.com
3. Former Canadiens defenceman Odelein dies at 58  tsn.ca
4. Former Penguins defenseman Lyle Odelein dies at 58  Pittsburgh Post-Gazette
5. Former NHL defenseman Lyle Odelein passes away at 58  Daily Faceoff

Oh my gourd: B.C. Giant Pumpkin Weigh Off comes down to 1-pound difference  CTV News

Oh my gourd: B.C. Giant Pumpkin Weigh Off comes down to 1-pound difference  CTV News

The Florida Gators certainly aren't the 2019 LSU Tigers.

They might not even be the 2019 version of the Florida Gators.

The number eight team in the country traveled to Columbia, Missouri, and ran into an absolute buzzsaw, as the Tigers took the Gators behind the woodshed in a 45-17 victory on Saturday.

FLORIDA GATORS FACE MISSOURI TIGERS IN COLLEGE FOOTBALL MATCHUP WHERE THE OVER LOOKS LIKE THE PLAY

It seemed like anything that could go right for Mizzou did.

The Tigers were able to establish their dominance on both lines of scrimmage, putting up 560 total yards and holding Florida to a shockingly low 42 yards on the ground.

Jadan Baugh, who came into the game leading the SEC in rushing yards, could hardly get it going this afternoon, only rushing for 13 yards on 12 carries.

CLICK HERE FOR MORE OUTKICK SPORTS COVERAGE

That was by design, as head coach Eli Drinkwitz revealed in his post game presser on the field.

While Baugh entered the day with Heisman aspirations, it was Missouri quarterback Austin Simmons who put on an award-winning performance.

The former Ole Miss starter was about as perfect as anyone could have asked for, eviscerating Florida's secondary to the tune of 340 yards and two scores through the air.

Missouri showed a ton of resolve, regrouping from their loss last week to Mississippi State and winning a home game against a ranked opponent for the first time since 2024.

For the Gators, Faurot Field has proved to be a house of horrors, and Saturday afternoon was no different.

The game was never close after halftime, and at no point did the usually explosive Florida offense look threatening to the home team.

Now, first year head coach Jon Sumrall will have to regroup and answer some tough questions.

It doesn't get any easier for the Gators either.

South Carolina comes to town, then Florida goes to Austin to take on Texas before a bye week.

Then the Gators will take on archrival Georgia in Atlanta.

That stretch will tell everyone in Gainesville what this team and their new head coach is all about.

Florida didn't handle being a top-ten team very well, and now they'll have to do a bit of climbing to get back to that spot.

For the time being, however, this one will sting.

Several of today's papers feature Andy Burnham's latest plans as PM, including experts warning of a potential tax rise to help cover his social care plan.

1. Tens of thousands protest in Spain after failed housing reforms  Al Jazeera
2. 'Anger in the streets': Tens of thousands protest in Spain over housing crisis  BBC
3. What to know about Spain's housing protests sparked by the eviction of the 87-year-old Maricarmen  Yahoo! Finance Canada
4. Nearly 500,000 people protest in Madrid over Spain's housing crisis  Euronews.com
5. Protests over housing flare in Spain after relief measures rejected  CTV News

1. Tom Cruise Stands Up for ‘Digger’ Amid Tough Box Office: “I’m So Proud of What We Created”  The Hollywood Reporter
2. Digger is poised to be one of the biggest box-office flops of the year  CBC
3. ‘Digger’ Review: Even Tom Cruise Can’t Save This Strained Satire  The New York Times
4. Box Office: ‘Digger’ Nosediving With $3.4 Million on Opening Day, ‘Verity’ Lands at No. 1 With $15.1 Million on Friday  Variety
5. Tom Cruise’s ‘Digger’ Plunging at Box Office With Less Than $10M as ‘Verity’ Leads  The Hollywood Reporter

1. Former Canadiens defenceman Lyle Odelein dies at age 58 from heart attack  Montreal Gazette
2. Former Canadiens defenceman Odelein dies at 58  TSN
3. Odelein dies at 58, was first Blue Jackets captain  NHL.com
4. Former Penguins defenseman Lyle Odelein dies at 58  Pittsburgh Post-Gazette
5. Montreal Canadiens defenceman Lyle Odelein, who won a Stanley Cup in 1993, dead at 58  CBC

1. Former Canadiens defenceman Lyle Odelein dies at age 58 from heart attack  Montreal Gazette
2. Odelein dies at 58, was first Blue Jackets captain  NHL.com
3. Former Penguins defenseman Lyle Odelein dies at 58  Pittsburgh Post-Gazette
4. Lyle Odelein, Stanley Cup-winning defenseman and historic captain, dead at 58  New York Post
5. Former Canadiens defenceman Odelein dies at 58  TSN

Michael O'Keefe is getting candid about what it was like on the set of the hit 1980 movie "Caddyshack."

During a recent interview with Page Six, the 71-year-old actor shared that there was a lot of cocaine on the set of the classic comedy and claimed the drug was even accounted for in the movie's budget, with the actor noting, "there was some miscellaneous item."

"It was the 70s," he said. "That’s what was happening back then. People were just treating it like it was toothpaste, and you had to do it twice a day to stay healthy."

The movie was filmed in 1979 and released in 1980, and also starred Ted Knight, Chevy Chase, Bill Murray and Rodney Dangerfield and was set at the fictional Bushwood Country Club.

TOM HARDY'S 'MOBLAND' DRAMA TOPS HOLLYWOOD'S MOST NOTORIOUS ON-SET MELTDOWNS AND FEUDS

When reflecting on the drug use on set, O'Keefe recalled doing cocaine before filming certain scenes, telling Page Six that when he watches those scenes now, "it was not my favorite memory," and that he is "not too happy about them."

"But I can report to you that right after that movie, during that movie, was the last time I ever did anything like cocaine," he said. "I realized that it was a terrible thing to get involved [with], and like so many things in the drug world, it looked like fun, but in reality, it wasn’t."

Part of the reason he decided to take a step back from drugs was the death of Doug Kenney, who co-wrote and produced "Caddyshack."

He called Kenney's death "a huge wake-up call." Kenney died at 33 after falling from a cliff in Hawaii in 1980.

GET ENTERTAINMENT SCOOP DELIVERED RIGHT TO YOUR EMAIL BY CLICKING HERE

LIKE WHAT YOU'RE READING? CLICK HERE FOR MORE ENTERTAINMENT NEWS

"[He was] one of the most affable, intelligent, funny people in the world. … Was strung out on cocaine, got depressed, and committed suicide," he said. "It was truly a result of drug addiction, and that was a huge wake-up call."

Prior to starring in "Caddyshack," O'Keefe had his breakthrough starring in "The Great Santini," which earned him an Academy Award nomination for best supporting actor.

He later starred in "Ironweed," "Frozen River" and, most recently, the Apple TV series "Your Friends & Neighbors," in which he plays Ron Cooper, the father of Jon Hamm's Andrew "Coop" Cooper. His most recognizable role remains Danny Noonan in "Caddyshack."

PUT YOUR ENTERTAINMENT KNOWLEDGE TO THE TEST AND SEE HOW YOU SCORE

"We always talk about how we got lucky young, and didn't know what we had," he told Yahoo in July 2020. "As actors, we don't want to be pigeonholed, so while I was always glad to be in 'Caddyshack,' I sometimes wished that people would acknowledge my other work."

He added: "But then I had this one experience with a wardrobe designer who told me that her father died of leukemia and for the last six weeks before his death, they would gather as a family and watch 'Caddyshack.' 

That really changed my feelings about what the movie means to people and what it means to me to be a part of it."

Tennessee officials are still investigating why death row inmate Christa Pike survived an execution attempt after receiving two doses of pentobarbital, a drug intended to render a person unconscious and ultimately cause death.

While the immediate focus has been on what went wrong inside the execution chamber, experts say Pike’s case has also renewed scrutiny of a problem that has been building for more than a decade: how states obtain lethal injection drugs after pharmaceutical companies moved aggressively to keep their products from being used in executions. Despite those efforts, pentobarbital remains the primary execution drug used by many death-penalty states, making questions about sourcing, testing and oversight especially significant.

The issue has reshaped how many states carry out executions, forcing them to change drug protocols, seek alternative suppliers and adopt increasingly secretive procurement practices.

“Drug shortages have devastated this country’s execution process to an unparalleled degree,” Deborah Denno, a Fordham University law professor who has studied lethal injection for decades, told Newsweek on Saturday.

How Pharmaceutical Companies Changed the Death Penalty

For years, states relied on commercially manufactured drugs obtained through traditional pharmaceutical channels.

That began to change after major drug manufacturers objected to having medicines designed to treat patients used in executions.

According to Corinna Barrett Lain, a University of Richmond law professor and author of Secrets of the Killing State: The Untold Story of Lethal Injection, pharmaceutical companies have spent years trying to prevent their products from reaching execution chambers.

“The bottom line is these drug companies, from the start, did not want their drugs being used in lethal injections with executions,” Lain told Newsweek on Saturday.

Drugmakers increasingly adopted distribution controls and contractual restrictions barring execution use. The result, according to Lain, is that states seeking lethal injection drugs are now forced to look elsewhere.

“Now states trying to buy drugs for lethal injection are stuck either intentionally breaching private contracts, and getting sued when they are discovered doing so, or buying compounded drugs from whatever compounding pharmacy is willing to sell a sterile injectable barbiturate without a prescription for cash in an under-the-table transaction,” she said.

The Rise of Secret Supply Chains

As pharmaceutical companies tightened restrictions, states increasingly turned to alternative methods of obtaining execution drugs.

Some relied on compounding pharmacies, which create customized formulations of drugs rather than mass-produced pharmaceutical products. Others sought alternative suppliers or adopted increasingly secretive procurement practices.

Lain said those shifts have fundamentally changed the execution-drug market.

Joel Zivot, a professor at Emory University School of Medicine, said the restrictions imposed by drug manufacturers forced states to seek alternative sources of execution drugs.

“A gray market usually means legal goods moving through channels the manufacturer never authorized,” he told Newsweek on Saturday. “None of the pathways states now use to obtain execution drugs is a white market. Some fit the gray description. Others have crossed into unlawful territory.”

Asked whether the term “gray market” accurately describes the current system, Lain replied: “Gray market and black market. Absolutely.”

Federal authorities have previously blocked or seized imported execution drugs intended for several states, while courts have reviewed disputes involving overseas suppliers and execution-drug imports.

The problem, according to experts, is that secrecy makes it difficult to know exactly how states obtain many of the drugs they use.

Why Secrecy Has Become So Important

States generally argue that supplier secrecy is necessary because manufacturers and vendors could face public pressure, boycotts or litigation if their identities become public.

Critics say secrecy serves another purpose.

“States can’t fix what’s broken with lethal injection, and if you can’t fix it, the other option is to hide it,” Lain said. “It is actually easier for states to fight over secrecy than to reveal the indefensible details of the suppliers they’ve used.”

Zivot likewise argued that secrecy itself has become central to the system.

“Secrecy makes independent evaluation impossible, and that is its purpose,” he said.

Without public information about suppliers, storage methods and testing procedures, outside experts cannot independently evaluate the quality or reliability of execution drugs, he said.

“Without knowing who made a drug, how it was stored and whether it was tested, no one, including the courts, can judge whether it will work as the state claims,” Zivot said.

Denno said secrecy has steadily expanded over the past two decades.

“The secrecy prevents a systematic analysis,” she said. “Yet, all of my research suggests these efforts to get drugs are more opaque and unconventional than ever.”

The Quality-Control Question

In conventional medicine, intravenous drugs undergo extensive testing and quality-control reviews. Potency, sterility, stability and contamination levels are all subject to regulatory scrutiny.

Questions about execution drugs extend beyond where they come from.

Execution drugs often operate under a different system.

“The question uses the language of medicine, and these chemicals are not medicine,” Zivot said. “They are intended as poisons, which turns the usual safety questions upside down.”

The distinction matters, he said.

With medicine, regulators worry a drug may be too potent. In an execution setting, a drug that is weaker than expected may fail to kill.

“Because sourcing, storage and testing are kept secret, no one outside the process can say what standards, if any, apply,” Zivot said. “That uncertainty is itself the problem.”

Tennessee has faced similar questions before. In 2022, Governor Bill Lee paused executions and ordered an independent review after officials discovered the state had failed to follow its own lethal injection procedures. The review later found that drugs prepared for executions had not consistently received all required testing, prompting Tennessee to revise its protocols before executions resumed in 2025.

Yet the state’s handling of execution drugs has remained under scrutiny.

What Christa Pike’s Case Reveals

Lain said she was unaware of another modern case in which an inmate appeared to survive after lethal-injection drugs had actually been administered. Based on publicly reported evidence, she said IV infiltration appears the most likely explanation, meaning the pentobarbital may have entered surrounding tissue rather than the bloodstream.

Pike’s attorneys have similarly argued that execution personnel failed to recognize that IV lines were improperly placed or that veins had blown during the procedure. Tennessee’s official review remains ongoing.

Regardless of the ultimate findings, both Lain and Zivot say the episode highlights broader vulnerabilities in the lethal-injection process.

“The death row population is a geriatric population with histories of poor health and often IV drug use,” Lain said. “This is a demographic with notoriously weak veins. That’s a problem inherent to lethal injection. You’re not going to be able to fix that.”

Zivot pointed to similar concerns.

“The execution team must place and maintain an IV line in a person who may have difficult veins,” he said. “And there is no medical plan for when things go wrong.”

Emergency vehicles leave Riverbend Maximum Security Institution after the execution of Christa Pike was halted Wednesday, Sept. 30, 2026, in Nashville, Tenn. (AP Photo/George Walker IV)Will Anything Change?

Despite the attention surrounding Pike’s case, experts disagree about whether it will lead to major reform.

Denno noted that execution failures have repeatedly generated public outrage only for states to continue using lethal injection afterward.

“Unfortunately, yes,” she said when asked whether states can continue relying on lethal injection despite mounting procurement problems. “Lethal injection botches are a never-ending story in the United States.”

States may continue searching for drugs, altering protocols and defending secrecy measures, she said.

But the underlying problem is unlikely to disappear.

Tennessee’s investigation may ultimately determine what happened in Pike’s execution attempt. But experts say the episode has also highlighted a separate question: whether states can continue relying on drugs that have become increasingly difficult to obtain, test and scrutinize.

Denno argued that a system originally intended to make executions appear more clinical and humane is now confronting a fundamental contradiction: It depends on drugs that the companies producing them increasingly do not want associated with executions.

Related Articles

• How George Clooney's Possible 2028 Dem President Picks Are Faring
• The Pro-Data Center Lawmakers Most at Risk in the Midterms
• How El Niño Could Reshape Thanksgiving and Christmas Travel

Start your unlimited Newsweek trial

This article originally appeared on NEWSWEEK at https://www.newsweek.com/christa-pike-botched-execution-secretive-drug-supply-chain-12521497

Director of National Intelligence Jay Clayton will lead the administration's AI policy, The Wall Street Journal reported on Saturday.

Prime Minister Mark Carney has said the military is running scenarios in the unlikely case the US invades Canada.